Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 514-519

  Maruyama, Riichiroh ^a   Toyooka, Shinichi ^a   Toyooka, Kiyomi O ^a   Virmani, Arvind K ^a   Zöchbauer Müller, Sabine ^a   Farinas, Alfredo J ^a   Minna, John D ^a   McConnell, John ^a   Frenkel, Eugene P ^a   Gazdar, Adi F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER;

AGED; AGED, 80 AND OVER; DNA METHYLATION; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS;

EID: 0036184623     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Cancer statistics 2000
2. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden
3. Alterations in DNA methylation: A fundamental aspect of neoplasia
4. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
5. A gene hypermethylation profile of human cancer
6. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
7. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
8. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia
9. Should Gleason score 7 prostate cancer be considered a unique grade category?
10. Aberrant promoter methylation of multiple genes in non-small cell lung cancers
11. Prostate specific antigen and Gleason grade: An immunohistochemical study of prostate cancer
12. Biological determinants of cancer progression in men with prostate cancer
13. CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: A new prostate cancer biomarker
14. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer
15. Promoter methylation and silencing of the retinoic acid receptor-β gene in lung carcinomas
16. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
17. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
18. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
19. Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma
20. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma
21. The H-cadherin (CDH13) gene is inactivated in human lung cancer
22. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas
23. Mutations of the APC (adenomatous polyposis coli) gene
24. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer
25. Promoter methylation and inactivation of the adenomatous polyposis coli (APC) gene in breast and lung carcinomas
26. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens
27. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
28. Fragile histidine triad gene expression in primary prostate cancer and in an in vitro model
29. Molecular analysis of the FHIT gene in human prostate cancer
30. CpG-island methylation in aging and cancer
31. Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus
32. 5′CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer
33. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia
34. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients
35. Inactivation of the DNA repair gene O-6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
36. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation